Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban

NCT03326063 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Nasal Polyps
Asthma, Aspirin-Induced
Aspirin-exacerbated Respiratory Disease
Aspirin-Sensitive Asthma With Nasal Polyps

Interventions

DRUG: Ifetroban
DRUG: Placebo

Sponsor

Brigham and Women's Hospital